JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Rovelizumab is a humanized monoclonal antibody which targets Integrin beta-2 (CD18) & Integrin alpha-L (CD11a) + Integrin alpha-M (CD11b).